Assessment of Long-Term Maintenance of OCS Reduction and Efficacy in the Dupilumab LIBERTY ASTHMA TRAVERSE Extension Study

被引：0

作者：

Sher, L. ^{[1
]}

Wechsler, M. ^{[2
]}

Rabe, K. F. ^{[3
,4
]}

Maspero, J. F. ^{[5
]}

Daizadeh, N. ^{[6
]}

Mao, X. ^{[7
]}

Ortiz, B. ^{[8
]}

Mannent, L. P. ^{[9
]}

Laws, E. ^{[7
]}

Ruddy, M. K. ^{[8
]}

Pandit-Abid, N. ^{[7
]}

Lederer, D. J. ^{[8
]}

Hardin, M. E. ^{[6
]}

机构：

[1] Peninsula Res Associates, Rolling Hills Estates, CA USA

[2] Natl Jewish Hlth, Denver, CO USA

[3] Airway Res Ctr North ARCN, LungenClin Grosshansdorf, Grosshansdorf, Germany

[4] Univ Kiel, Airway Res Ctr North ARCN, Kiel, Germany

[5] Fdn CIDEA, Buenos Aires, DF, Argentina

[6] Sanofi, Cambridge, MA USA

[7] Sanofi, Bridgewater, NJ USA

[8] Regeneron Pharmaceut Inc, 777 Old Saw Mill River Rd, Tarrytown, NY 10591 USA

[9] Sanofi, Chilly Mazarin, France

来源：

关键词：

D O I：

暂无

中图分类号：

R4 [临床医学];

学科分类号：

1002 ; 100602 ;

摘要：

A1441

引用

页数：2